We're building a better ClinicalTrials.gov. Check it out and tell us what you think!
Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT04318080
Brief Title: Tislelizumab in Participants With Relapsed or Refractory Classical Hodgkin Lymphoma (TIRHOL)

First Submitted : March 20, 2020
First Submitted that Met QC Criteria : March 20, 2020
First Posted : March 23, 2020

Last Update Submitted that Met QC Criteria : September 21, 2022
Last Update Posted : September 23, 2022